Could Core Issues in ME/CFS Be Cropping Up? Report from the IACFS/ME Conference #4
The 4th in a series of blogs on the 2022 IACFS/ME International Conference finds two new metabolomic studies that highlighted three problems that have cropped up recently in other studies: fatty acid metabolism, cell membrane damage, and energy production. The first...
All Together Now? Did Lipkin’s Latest ME/CFS Study Put the Pieces Together?
Step by step Lipkin’s metabolomic study produces a coherent picture of mitochondrial dysfunction The really neat thing about Ian Lipkin’s latest work on ME/CFS is how well all the results fit together. Health Rising reported on the preprint of this...
Ron Davis’s ME/CFS Moment: The “Core Technology Disrupter” Gets a Win
Ron Davis gets a win but will he ever be given the chance to bring his core disrupting technologies to ME/CFS? An ME/CFS Moment: something unexpected happens that indicates the tide is rising for the ME/CFS field. This could include something like a big grant...
$8 Million Clinical Trial of a Mitochondrial Booster Underway in ME/CFS
An $8 million clinical trial of a mitochondrial enhancer, no less, in ME/CFS? I thought I was hearing things but it was so, and, in the end, it even makes sense given how rapidly some parts of this field are moving forward. But first, a little backstory. A...
Novel Approach Brings New Insights Into ME/CFS Mitochondria
Frustrated for 10 years in his desire to study ME/CFS, Paul Fisher of LaTrobe University in Australia made the most of it when he got the chance He and his lead researcher on these studies, Daniel Missailidis, have rolled off four studies and two reviews in the last...Lives Interrupted Latest Story
Allyn Archer
Atlanta, United States
Former occupation: Architect, Professor of Architecture
$2,768,291
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
